e-ISICEM 2020


International Symposium on Intensive Care and Emergency Medicine

Thermo Fisher Scientific is sponsor of the International Symposium on Intensive Care and Emergency Medicine (ISICEM). We recommend the following webinars, highlighting the biomarker Procalcitonin:

Implementation of PCT-aided ABS protocols

From real-life integration to long-term benefits and MDRO reduction

Free on-demand webinar


e-isicem-2020-speaker-e-giamarellosPCT-aided antimicrobial treatment in sepsis: impact on infections by MDRO and Clostridioides difficile and mortality
Evangelos J. Giamarellos-Bourboulis, University of Athens, Greece

e-isicem-2020-speaker-a-kwaImplementing PCT into antibiotic stewardship (ABS) protocols – impact on clinical and health-economic outcome
Andrea Kwa Lay Hoon, Singapore General Hospital, Singapore

During this webinar, participants will:

  • Get to know the most recent data on the long-term impact of PCT-guided antibiotic stewardship protocols in the rate of infections caused by MDRO and Clostridioides difficile and on mortality.
  • Gain an understanding from real-life experience of how to integrate PCT algorithms into hospital antibiotic stewardship programs and their medical and health-economic impact.

Register for free webinar >

PCT and MR-proADM

Utility to support decision making during COVID-19 and beyond

September 17, 2020, 11:45-12:30 CET

This symposium provides insights into the practical implementation of both biomarkers in the real-life management of COVID-19 patients.

  • Gain an understanding of the utility of Procalcitonin in the early identification of COVID-19 patients at low risk of bacterial coinfection and adverse outcomes.
  • Get to know new data on the prognostic significance of MR-proADM measured through hospital admissions of COVID-19 patients.
  • Go beyond COVID-19 and be the first to learn about the results of the interventional trial IDEAL and how MR-proADM can improve discharge decisions.


e-isicem-2020-speaker-m-mansourClinical utility of procalcitonin in the management of COVID-19 patients
Michael K. Mansour, Massachusetts General Hospital, Boston, USA

e-isicem-2020-speaker-p-schuetzPrognostic significance of MR-proADM admission levels in COVID-19 patients
Philipp Schuetz, Medizinische Universitätsklinik, Kantonsspital Aarau, Switzerland

e-isicem-2020-speaker-j-gonzalezImproving discharge in the ED: identifying patients with suspicion of infection in the ED who have low disease severity using MR-proADM
Juan González del Castillo, Hospital Clínico San Carlos, Madrid, Spain

  • Live Q & A

Register for e-ISICEM symposium >

e-ISICEM website >

thermo scientific applied biosystems invitrogen fisher scientific unity lab service